EUVIMEDEUVIMED entdecken
Crossref

Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells

Man-Yuan Li, Jiao Zhang, Xiao Lu, Dong Zhou, Xu-Feng Deng, Quan-Xing Liu, Ji-Gang Dai, Hong Zheng iD

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-023-04589-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Man-Yuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Excellent Talent Program of Chongqing, Key Project of Frontier Science Research of Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: LUAD (Lung adenocarcinoma), the most common subtype of lung carcinoma and one of the highest incidences and mortality cancers in the world remains still a substantial treatment challenge. Ivermectin, an avermectin derivative, has been traditionally used as an antiparasitic agent in human and veterinary medicine practice during the last few decades. Though ivermectin has been shown to be effective against a variety of cancers, however, there is few available data reporting the antitumor effects of ivermectin in LUAD. METHODS: The effect of ivermectin on cell viability and proliferative ability of LUAD cells was evaluated using CCK-8 and colony formation assay. Apoptosis rate and autophagy flux were detected using flow cytometry based on PI/Annexin V staining and confocal laser scanning microscope based on LC3-GFP/RFP puncta, respectively. Western blotting experiment was conducted to verify the results of changes in apoptosis and autophagy. LUAD-TCGA and GEO databases were used to analyse the expression and predictive value of PAK1 in LUAD patients. Xenograft model and immumohistochemical staining were used for verification of the inhibitor effect of ivermectin in vivo. RESULTS: Ivermectin treatment strikingly impeded the colony formation, and the viability of the cell, along with cell proliferation, and caused the apoptosis and enhanced autophagy flux in LUAD cells. In addition, ivermectin-induced nonprotective autophagy was confirmed by treating LUAD cells with 3-MA, an autophagy inhibitor. Mechanistically, we found that ivermectin inhibited PAK1 protein expression in LUAD cells and we confirmed that overexpression of PAK1 substantially inhibited ivermectin-induced autophagy in LUAD cells. Based on TCGA and GEO databases, PAK1 was highly expressed in LUAD tissues as compared with normal tissues. Furthermore, LUAD patients with high PAK1 level have poor overall survival. Finally, in vivo experiments revealed that ivermectin efficiently suppressed the cellular growth of LUAD among nude mice. CONCLUSION: This study not only revealed the mechanism of ivermectin inhibited the growth of LUAD but also supported an important theoretical basis for the development of ivermectin during the therapy for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsAnimalsMiceHumansIvermectinMice, NudeAutophagyCell ProliferationApoptosisp21-Activated Kinases

Stichwörter der Autor:innen

ApoptosisAutophagyIvermectinLung adenocarcinomaPAK1

Substanzen

IvermectinPAK1 protein, humanp21-Activated Kinases

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China.
  • Department of Thoracic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China. daijigang@tmmu.edu.cn.
  • Department of Thoracic Surgery, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China. ziecoe@tmmu.edu.cn.

ORCID-Profile: Hong Zheng

Förderung

  • National Natural Science Foundation of China
  • Excellent Talent Program of Chongqing
  • Key Project of Frontier Science Research of Chinese Academy of Sciences

Zitieren

APA

Li, M. Y., Zhang, J., Lu, X., Zhou, D., Deng, X. F., Liu, Q. X., Dai, J. G., & Zheng, H. (2024). Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-023-04589-6

Vancouver

Li MY, Zhang J, Lu X, Zhou D, Deng XF, Liu QX, et al. Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-023-04589-6

BibTeX
@article{Li2024,
  author = {Li, Man-Yuan and Zhang, Jiao and Lu, Xiao and Zhou, Dong and Deng, Xu-Feng and Liu, Quan-Xing and Dai, Ji-Gang and Zheng, Hong},
  title = {Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-023-04589-6}
}
Kostenlos starten →